CERUS CORP

CERS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $233.8M $201.3M $178.4M $179.0M $157.8M $103.3M $92.0M $76.9M
Product Revenue $156.2M $161.8M $130.8M $91.9M $74.7M $60.1M
Government Contract Revenue $22.2M $17.2M $27.0M $11.4M $17.2M $16.8M
License and Royalty Revenue $0 $0 $0 $0 $0 $0
Cost of Revenue $41.2M $33.4M $31.6M
Gross Profit $62.1M $58.5M $45.2M
Gross Margin 60.1% 63.7% 58.8%
Operating Expenses
Research & Development
SG&A Expense $80.9M $75.9M $75.5M $83.3M $81.3M $67.0M $66.2M $56.8M
Operating Income $-8.7M $-14.2M $-30.1M $-34.1M $-48.9M $-58.3M $-66.2M $-55.0M
Operating Margin -3.7% -7.1% -16.8% -19.0% -31.0% -56.5% -72.0% -71.5%
Interest Expense $8.4M $5.8M $4.9M $3.7M $6.1M $4.0M
Pretax Income $-15.3M $-20.8M $-37.3M $-42.3M $-54.1M $-59.6M $-71.0M $-57.3M
Income Tax Expense $354.0K $205.0K $325.0K $488.0K $319.0K $284.0K $263.0K $229.0K
Net Income $-15.6M $-20.9M $-37.5M $-42.8M $-54.4M $-59.9M $-71.2M $-57.6M
Net Margin -6.7% -10.4% -21.0% -23.9% -34.5% -58.0% -77.5% -74.9%
EPS (Basic) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51 $-0.44
EPS (Diluted) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51 $-0.44
Shares Outstanding (Basic) 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M 131.7M
Shares Outstanding (Diluted) 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M 131.7M
Dividends Per Share
← Newer Page 1 of 3 Older →